Personal information

Other IDs

ResearcherID: AAC-6008-2019

Keywords

Radiation therapy, Healthy brain, Brain tumors, Biomedical imaging (MRI-PET), Radiobiology, Preclinical models

Countries

France

Activities

Collapse all

Employment (5)

Cyceron: Caen, Basse-Normandie, FR

2016-01 to present | Permanent position of research engineer (UMR6030-ISTCT Unit / CERVOxy group)
Employment
Source: Self-asserted source
Pérès EA

Institut de radiobiologie cellulaire et moléculaire: Fontenay-aux-Roses, Île-de-France, FR

2014-01 to 2016-01 | Postdoctoral Researcher (Laboratoire de RadioPathologie)
Employment
Source: Self-asserted source
Pérès EA

CEA Saclay: Gif-sur-Yvette, Île-de-France, FR

2014-01 to 2016-01 | Postdoctoral Researcher (NeuroSpin - UNIRS Unit)
Employment
Source: Self-asserted source
Pérès EA

Cyceron: Caen, Basse-Normandie, FR

2012-12 to 2013-05 | Postdoctoral Researcher (UMR6301-ISTCT Unit / CERVOxy group)
Employment
Source: Self-asserted source
Pérès EA

Cyceron: Caen, Basse-Normandie, FR

2009-10 to 2012-11 | PhD Student (UMR6301-ISTCT Unit / CERVOxy group)
Employment
Source: Self-asserted source
Pérès EA

Education and qualifications (5)

Université de Caen Normandie: Caen, FR

2024-07-02 to present | Habilitation à Diriger des Recherches (HDR)
Education
Source: Self-asserted source
Pérès EA

Normandie Université: Caen, FR

2009-10 to 2012-11 | Doctorat Médecine et Santé, spécialité Aspects Moléculaires et Cellulaires de la Biologie (Ecole doctorale Normande Biologie Intégrative, Santé et Environnement (EdNBISE))
Education
Source: Self-asserted source
Pérès EA

Université de Caen Normandie: Caen, Normandie, FR

2008-09 to 2009-07 | Master 2 Recherche de Biologie et Santé, spécialité Neurosciences et Imagerie de la Santé (UFR des Sciences)
Education
Source: Self-asserted source
Pérès EA

Université de Caen Normandie: Caen, Normandie, FR

2007-09 to 2008-06 | : Master 1 Recherche de Biologie Fondamentale et Appliquée, spécialité Neurosciences (UFR des Sciences)
Education
Source: Self-asserted source
Pérès EA

Université de Caen Normandie: Caen, Normandie, FR

2005-09 to 2007-06 | Licence Sciences du Vivant, spécialité Neurosciences (UFR des Sciences)
Education
Source: Self-asserted source
Pérès EA

Funding (4)

Une thérapie matricielle contre les lésions cérébrales et les déficits cognitifs induits par la radiothérapie (Brain-MATRiX)

2021 to 2025 | Grant
Institut National Du Cancer (Boulogne-Billancourt, Ile de France, FR)
Source: Self-asserted source
Pérès EA

L’activité physique : une thérapie pour contrer les effets secondaires de la radiothérapie cérébrale ?

2021 to 2024 | Grant
Centre National de la Recherche Scientifique (Caen, Normandie, FR)
Source: Self-asserted source
Pérès EA

Evaluation of radiation-induced brain damage by exposure to low and high doses of ionizing radiation in an adult rat model.

2017-01 to 2017-12 | Grant
Cancéropôle Nord-Ouest (Caen, Normandie et Hauts-de-France, FR)
GRANT_NUMBER: X
Source: Self-asserted source
Pérès EA

Caractérisation des atteintes neuropathologiques induites par les faibles doses d’irradiation chez la souris

2016 to 2019 | Grant
Fondation EDF (Paris, Ile-de-France, FR)
Source: Self-asserted source
Pérès EA

Works (24)

Deformation-based morphometry: a sensitive imaging approach to detect radiation-induced brain injury?

Cancer Imaging
2024-07-18 | Journal article
DOI: 10.1186/s40644-024-00736-1
HAL: hal-04652900
Contributors: Carole Brunaud; Samuel Valable; Gwenn Ropars; Fatima-Azzahra Dwiri; Mikaël Naveau; Jérôme Toutain; Myriam Bernaudin; Thomas Freret; Marianne Léger; Omar Touzani et al.
Source: Self-asserted source
Pérès EA via HAL

Physical Activity Attenuates Brain Irradiation-Associated Skeletal Muscle Damage in the Rat

International Journal of Radiation Oncology*Biology*Physics
2024-03 | Journal article
DOI: 10.1016/j.ijrobp.2023.10.007
Part of ISSN: 0360-3016
Contributors: Julie Bécam; Gwenn Ropars; Fatima-Azzahra Dwiri; Carole Brunaud; Jérôme Toutain; Laurent Chazalviel; Mikaël Naveau; Samuel Valable; Myriam Bernaudin; Omar Touzani et al.
Source: Self-asserted source
Pérès EA

Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies

EJNMMI Research
2023-11-25 | Journal article
DOI: 10.1186/s13550-023-01052-8
Part of ISSN: 2191-219X
Contributors: Jade Fantin; Jérôme Toutain; Elodie A. Pérès; Benoit Bernay; Sarina Maya Mehani; Charly Helaine; Mickael Bourgeois; Carole Brunaud; Laurent Chazalviel; Julien Pontin et al.
Source: Self-asserted source
Pérès EA

XLF/Cernunnos loss impairs mouse brain development by altering symmetric proliferative divisions of neural progenitors

Cell Reports
2023-04 | Journal article
DOI: 10.1016/j.celrep.2023.112342
Part of ISSN: 2211-1247
Contributors: Amandine Bery; Olivier Etienne; Laura Mouton; Sofiane Mokrani; Christine Granotier-Beckers; Laurent R. Gauthier; Feat-Vetel; Thierry Kortulewski; Elodie A. Pérès; Chantal Desmaze et al.
Source: Self-asserted source
Pérès EA

The Reactive Species Interactome in the Brain

Antioxidants & Redox Signaling
2021-11-10 | Journal article
DOI: 10.1089/ars.2020.8238
Contributors: Elise Malard; Samuel Valable; Myriam Bernaudin; Elodie Pérès; Laurent Chatre
Source: check_circle
Crossref

Anticancer Drugs for Intra-Arterial Treatment of Colorectal Cancer Liver Metastases: In-Vitro Screening after Short Exposure Time

Pharmaceuticals
2021-07-01 | Journal article
DOI: 10.3390/ph14070639
Contributors: Audrey Fohlen; Karim Bordji; Eric Assenat; Céline Gongora; Céline Bazille; Jérémy Boulonnais; Mikaël Naveau; Cécile Breuil; Elodie A. Pérès; Myriam Bernaudin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Noninvasive Assessment of Neurodevelopmental Disorders after In Utero Irradiation in Mice: An In Vivo Anatomical and Diffusion MRI Study

Radiation Research
2021-04-07 | Journal article
DOI: 10.1667/rade-20-00136.1
Part of ISSN: 0033-7587
Source: Self-asserted source
Pérès EA

Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study

Cancers
2020-11-30 | Journal article
DOI: 10.3390/cancers12123585
Contributors: Charly Helaine; Aurélie E. Ferré; Marine M. Leblond; Elodie A. Pérès; Myriam Bernaudin; Samuel Valable; Edwige Petit
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes

Cancers
2020-07-23 | Journal article
DOI: 10.3390/cancers12082019
Contributors: Samuel Valable; Aurélie N. Gérault; Gaëlle Lambert; Marine M. Leblond; Clément Anfray; Jérôme Toutain; Karim Bordji; Edwige Petit; Myriam Bernaudin; Elodie A. Pérès
Source: check_circle
Crossref

SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines

International Journal of Molecular Sciences
2020-05-30 | Journal article
DOI: 10.3390/ijms21113917
Contributors: Filippo Torrisi; Luigi Minafra; Francesco P. Cammarata; Gaetano Savoca; Marco Calvaruso; Nunzio Vicario; Laura Maccari; Elodie A. Pérès; Hayriye Özçelik; Myriam Bernaudin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study

EJNMMI Research
2019-12 | Journal article
DOI: 10.1186/s13550-019-0586-6
Part of ISSN: 2191-219X
Source: Self-asserted source
Pérès EA

Hadrontherapy Interactions in Molecular and Cellular Biology

International Journal of Molecular Sciences
2019-12-24 | Journal article
DOI: 10.3390/ijms21010133
Contributors: Juliette Thariat; Samuel Valable; Carine Laurent; Siamak Haghdoost; Elodie A. Pérès; Myriam Bernaudin; François Sichel; Paul Lesueur; Mathieu Césaire; Edwige Petit et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

In vivo surface dosimetry with a scintillating fiber dosimeter in preclinical image‐guided radiotherapy

Medical Physics
2019-11-26 | Journal article
DOI: 10.1002/mp.13903
Part of ISSN: 0094-2405
Part of ISSN: 2473-4209
Source: Self-asserted source
Pérès EA

VCAM-1 Targeted Alpha-Particle Therapy for Early Brain Metastases

Neuro-Oncology
2019-09-20 | Journal article
DOI: 10.1093/neuonc/noz169
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Source: Self-asserted source
Pérès EA

Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas

The Journal of Molecular Diagnostics
2019-07 | Journal article
DOI: 10.1016/j.jmoldx.2019.03.007
Part of ISSN: 1525-1578
Source: Self-asserted source
Pérès EA
grade
Preferred source (of 2)‎

TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma

Neuro-Oncology
2019-06-10 | Journal article
DOI: 10.1093/neuonc/noz029
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Source: Self-asserted source
Pérès EA

Longitudinal Study of Irradiation-Induced Brain Microstructural Alterations With S-Index, a Diffusion MRI Biomarker, and MR Spectroscopy

International Journal of Radiation Oncology*Biology*Physics
2018-02 | Journal article
DOI: 10.1016/j.ijrobp.2018.01.070
Part of ISSN: 0360-3016
Contributors: Elodie Anne Pérès; Olivier Etienne; Antoine Grigis; Fawzi Boumezbeur; François Dominique Boussin; Denis Le Bihan
Source: Self-asserted source
Pérès EA via Crossref Metadata Search

M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma

Oncotarget
2017-08-07 | Journal article
DOI: 10.18632/oncotarget.19994
Part of ISSN: 1949-2553
Contributors: Marine M. Leblond; Elodie A. Pérès; Charly Helaine; Aurélie N. Gérault; Damien Moulin; Clément Anfray; Didier Divoux; Edwige Petit; Myriam Bernaudin Samuel Valable
Source: Self-asserted source
Pérès EA via Crossref Metadata Search

Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma

European Journal of Nuclear Medicine and Molecular Imaging
2015-11-05 | Journal article
DOI: 10.1007/s00259-015-3225-0
Part of ISSN: 1619-7070
Contributors: Aurélien Corroyer-Dulmont; Elodie A. Pérès; Aurélie N. Gérault; Ariel Savina; Fanny Bouquet; Didier Divoux; Jérôme Toutain; Méziane Ibazizène; Eric T. MacKenzie; Louisa Barré et al.
Source: Self-asserted source
Pérès EA via Crossref Metadata Search

IDH1R132HMutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia

BioMed Research International
2014 | Journal article
DOI: 10.1155/2014/198697
Part of ISSN: 2314-6133
Contributors: Xiao-Wei Wang; Marianne Labussière; Samuel Valable; Elodie A. Pérès; Jean-Sébastien Guillamo; Myriam Bernaudin; Marc Sanson
Source: Self-asserted source
Pérès EA via Crossref Metadata Search

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

Oncotarget
2014 | Journal article
DOI: 10.18632/oncotarget.2937
Part of ISSN: 1949-2553
Contributors: Elodie A. Pérès; Aurélie N. Gérault; Samuel Valable; Simon Roussel; Jérôme Toutain; Didier Divoux; Jean-Sébastien Guillamo; Marc Sanson; Myriam Bernaudin; Edwige Petit
Source: Self-asserted source
Pérès EA via Crossref Metadata Search

Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.

2013-04 | Journal article
DOI:

10.1515/hsz-2012-0318

PMID:

23399636
Contributors: Corroyer-Dulmont A; Pérès EA; Petit E; Durand L; Marteau L; Toutain J; Divoux D; Roussel S; MacKenzie ET; Barré L et al.
Source: Self-asserted source
Pérès EA via Europe PubMed Central

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

2013-01 | Journal article
DOI:

10.1093/neuonc/nos260

PMID:

23115160

PMC:

PMC3534417
Contributors: Corroyer-Dulmont A; Pérès EA; Petit E; Guillamo JS; Varoqueaux N; Roussel S; Toutain J; Divoux D; MacKenzie ET; Delamare J et al.
Source: Self-asserted source
Pérès EA via Europe PubMed Central

Targeting the erythropoietin receptor on glioma cells reduces tumour growth.

2011-10 | Journal article
DOI:

10.1016/j.yexcr.2011.06.011

PMID:

21749867
Contributors: Pérès EA; Valable S; Guillamo JS; Marteau L; Bernaudin JF; Roussel S; Lechapt-Zalcman E; Bernaudin M; Petit E
Source: Self-asserted source
Pérès EA via Europe PubMed Central

Peer review (2 reviews for 1 publication/grant)

Review activity for Cancers. (2)
How many people are using ORCID?